P. Gómez Pardo
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Cancer Research
- Molecular Biology
- Co-authors
- Aditya BardiaEva CiruelosJavier CortésWendy VerretFlorence DalencSara M. TolaneyOlivier TrédanDelphine Loirat
- Topics
- Advanced Breast Cancer Therapies (13 papers)Cancer Treatment and Pharmacology (13 papers)HER2/EGFR in Cancer Research (13 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
P. Gómez Pardo
26 papers receiving 704 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 566
- Pulmonary and Respiratory Medicine 367
- Radiology, Nuclear Medicine and Imaging 159
- Cancer Research 158
- Molecular Biology 91
Countries citing papers authored by P. Gómez Pardo
This map shows the geographic impact of P. Gómez Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gómez Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gómez Pardo more than expected).
Fields of papers citing papers by P. Gómez Pardo
This network shows the impact of papers produced by P. Gómez Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gómez Pardo. The network helps show where P. Gómez Pardo may publish in the future.
Co-authorship network of co-authors of P. Gómez Pardo
This figure shows the co-authorship network connecting the top 25 collaborators of P. Gómez Pardo. A scholar is included among the top collaborators of P. Gómez Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gómez Pardo. P. Gómez Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trialbreakdown → | 210 |
| 4 | 1 | |
| 5 | 18 | |
| 6 | 1 | |
| 7 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancerbreakdown → | 176 |
| 8 | 81 | |
| 9 | 19 | |
| 10 | 5 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 3 | |
| 14 | 104 | |
| 15 | 20 | |
| 16 | 3 | |
| 17 | 19 | |
| 18 | 6 | |
| 19 | 2 | |
| 20 | 1 |
About P. Gómez Pardo
P. Gómez Pardo is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 716 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (13 papers), Cancer Treatment and Pharmacology (13 papers) and HER2/EGFR in Cancer Research (13 papers). The work is most often cited by research in Oncology (566 citations), Pulmonary and Respiratory Medicine (367 citations) and Cancer Research (158 citations). P. Gómez Pardo has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Aditya Bardia, Eva Ciruelos, Javier Cortés, Wendy Verret, Florence Dalenc, Sara M. Tolaney, Olivier Trédan, Delphine Loirat, Komal Jhaveri and Frederik Marmé. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.